BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4432341
Number of visits today
1360
Number of downloads
4066471
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Vi C, Mandarano G, Shigdar S. Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach. Int J Mol Sci 2021;22:6163. [PMID: 34200484 DOI: 10.3390/ijms22116163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tran LH, Graulus GJ, Vincke C, Smiejkowska N, Kindt A, Devoogdt N, Muyldermans S, Adriaensens P, Guedens W. Nanobodies for the Early Detection of Ovarian Cancer. Int J Mol Sci 2022;23. [PMID: 36430166 DOI: 10.3390/ijms232213687] [Reference Citation Analysis]
2 Malatesta M. Molecular Imaging in Nanomedical Research 2.0. IJMS 2022;23:13011. [DOI: 10.3390/ijms232113011] [Reference Citation Analysis]
3 Ebrahimi F, Noaparast Z, Abedi SM, Hosseinimehr SJ. Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging. Med Oncol 2022;39:204. [PMID: 36175805 DOI: 10.1007/s12032-022-01798-6] [Reference Citation Analysis]
4 Nakhjavani M, Shigdar S. Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer. Pharmacol Res 2021;175:106019. [PMID: 34861397 DOI: 10.1016/j.phrs.2021.106019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Youssef A, Haskali MB, Gorringe KL. The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic. Cancers (Basel) 2021;13:5596. [PMID: 34830751 DOI: 10.3390/cancers13225596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345